DE   EN   ES   FR   IT   PT


Taufon

Препарат Тауфон. ФГУП "Московский эндокринный завод" Россия


Producer: Federal State Unitary Enterprise Moscow Endocrine Plant Russia

Code of automatic telephone exchange: S01XA

Release form: Liquid dosage forms. Drops are eye.

Indications to use: Cornea dystrophy. Cataract. Cornea injuries. Open angle glaucoma.


General characteristics. Structure:

Active ingredient: 40 mg of taurine in 1 ml of solution.

Excipients: methylparahydroxybenzoate (methylparaben), 1 M hydroxide sodium solution to pH 5,0, water for injections.




Pharmacological properties:

Pharmacodynamics. Taurine is the sulfur-containing amino acid which is formed in an organism in the course of cysteine transformation. Stimulates processes of a reparation and regeneration at the diseases of dystrophic character and diseases which are followed by sharp disturbance of metabolism of eye fabrics.

Contributes to normalization of functions of cellular membranes, activation of power and exchange processes, preservation of electrolytic composition of cytoplasm due to accumulation of K+ and Sa2+, improvement of conditions of carrying out nervous impulse.

Pharmacokinetics. At topical administration system absorption low.


Indications to use:

Drug is appointed the adult at:

- cornea dystrophies;

- senile, traumatic, beam and other types of cataracts;

- cornea injuries (as a stimulator of reparative processes);

- to primary open angle glaucoma in combination with (β-adrenoblockers ((((((((((for improvement of outflow of watery moisture).

At all indications drug is used as a part of complex therapy.


Route of administration and doses:

At cataracts Taufon appoint in the form of instillations 1-2 drops 2-4 times a day within three months. The course is repeated with a monthly interval.

At injuries and dystrophic diseases of a cornea apply in the same doses within one month.

At an open angle glaucoma (in combination with a butilaminogidroksipropoksifenok simetit methyloxadiazol color and its combined forms or Timololum) - on 1-2 drops pass 2 times, in 15-20 min. prior to purpose of one of antihypertensives, within 6 weeks with the subsequent cancellation for 2 weeks.


Features of use:

Pregnancy and lactation. There is no sufficient experiment on use of drug during pregnancy, feeding by a breast. Taufon's use for treatment of pregnant women and nursing mothers to destination of the attending physician is possible if the expected medical effect exceeds risk of development of possible side effects.


Side effects:

Allergic reactions. If the side effects specified in the instruction are aggravated, or you noticed any other side effects which are not specified in the instruction, report about it to the doctor.


Interaction with other medicines:

At patients with glaucoma (open-angle) considerable strengthening of hypotensive effect of β-adrenoblockers ((((((((((Timololum and butilaminogidroksi-methyloxadiazol color propoxyphenoxymethyl) in case of combined use with Taufon is noted.

Strengthening of effect is reached due to increase in coefficient of ease of outflow and decrease in products of watery moisture.


Contraindications:

Individual hypersensitivity to taurine, children's age up to 18 years.


Overdose:

Data on overdose are absent.


Storage conditions:

Drops eye 4%. 1,5 ml, 2 ml or 5 ml in a tube dropper polymeric. 1, 2, 4, 5 or 10 tube droppers with the application instruction of drug in a pack from a cardboard. 5 ml or 10 ml in a bottle dropper polymeric. The 1 or 2 bottle dropper with the application instruction of drug in a pack from a cardboard. The text of the application instruction a tube dropper or a bottle dropper is put on a pack. 5 ml in bottles glass. 1 bottle complete with a cover dropper in sterile execution and the application instruction of drug in a pack from a cardboard. 5 bottles in a blister strip packaging from a film polyvinyl chloride. 1 blister strip packaging complete with 5 covers droppers in sterile execution and the application instruction of drug in a pack from a cardboard.


Issue conditions:

According to the recipe


Packaging:

In the place protected from light at a temperature not above 15 °C (for drug in a tube droppers). In the place protected from light at a temperature not above 25 °C (for drug in a bottle droppers and in bottles). To store in the places unavailable to children. A period of validity - 2 years in a tube droppers. 3 years in a bottle droppers. 4 years in bottles. A drug period of validity after opening - 1 month. Not to use after the expiry date specified to a na to a forging.



Similar drugs

Препарат КардиоАктив Таурин. ФГУП "Московский эндокринный завод" Россия

Cardioasset Taurine

Metabolic means.



Препарат Таурин. ФГУП "Московский эндокринный завод" Россия

Taurine

Metabolic means.



Препарат Тауфон. ФГУП "Московский эндокринный завод" Россия

Taufon

Means which are applied in ophthalmology. Trophic means.



Препарат Таурин. ФГУП "Московский эндокринный завод" Россия

Taurine

Metabolic means.



Препарат Дибикор®. ФГУП "Московский эндокринный завод" Россия

Дибикор®

The means influencing the alimentary system and metabolic processes.



Препарат Тауфон. ФГУП "Московский эндокринный завод" Россия

Taufon

Drugs for treatment of diseases of eyes. The means regulating metabolic processes.



Препарат Тауфон. ФГУП "Московский эндокринный завод" Россия

Taufon

Metabolic means. Vitamin drug.



Препарат Таурин-АКОС . ФГУП "Московский эндокринный завод" Россия

Taurin-AKOS

Metabolic means.



Препарат Таурин Буфус 4%. ФГУП "Московский эндокринный завод" Россия

Taurine Bufus of 4%

Metabolic means.



Препарат Тауфон - Дарница, по 5 мл или 10 мл. ФГУП "Московский эндокринный завод" Россия

Taufon - Darnitsa, on 5 ml or 10 ml

The means operating on sense bodys.



Taurine

Other drugs for treatment of diseases of eyes





  • Сайт детского здоровья